Browse by Poster Presenter

Skip to main content

ASCPT 2024 Annual Meeting Main banner

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

K
Kang, Sanghoon

University of Florida College of Pharmacy Department of Pharmaceutics
PII-184 - TOWARDS ASSISTING POTENTIAL PREVENTION CLINICAL TRIALS OF BONE-PROTECTIVE THERAPIES FOR DUCHENNE MUSCULAR DYSTROPHY USING DEEP SEGMENTED IMAGING BIOMARKER
Sanghoon Kang
Favorite
Kardouh, Miramar

The University of North Carolina at Chapel Hill and Certara
OAI-002 - UTILIZING A MINIMAL PHYSIOLOGICALLY-BASED PHARMACOKINETIC (MPBPK) MODEL FOR PREDICTING MATERNAL AND FETAL EXPOSURE TO MONOCLONAL ANTIBODIES DURING PREGNANCY
Miramar Kardouh
Favorite
PT-001 - UTILIZING A MINIMAL PHYSIOLOGICALLY-BASED PHARMACOKINETIC (MPBPK) MODEL FOR PREDICTING MATERNAL AND FETAL EXPOSURE TO MONOCLONAL ANTIBODIES DURING PREGNANCY
Miramar Kardouh
Favorite
Karelina, Tatiana

InSysBio CY
PII-220 - RESPONSE TO LYMPHOCYTE DEPLETING AND LYMPHOCYTE MODULATING THERAPIES IN DIFFERENT POPULATIONS OF PATIENTS WITH MULTIPLE SCLEROSIS INVESTIGATED BY QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL
Tatiana Karelina
Favorite
Kawaguchi, Atsuhiro

Mitsubishi Tanabe Pharma Co
PII-133 - PHARMACOKINETICS OF EDARAVONE - COMPARISON OF EXPOSURE BETWEEN JAPANESE AND NON-JAPANESE BY POPULATION PHARMACOKINETIC ANALYSIS.
Atsuhiro Kawaguchi
Favorite
Keshavarz, Ali

Amylyx Pharmaceuticals, Inc.
LB-005 - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF AMX0035 IN PARTICIPANTS WITH AMYOTROPHIC LATERAL SCLEROSIS
Ali Keshavarz
Favorite
Kiesel, Brian

Bristol Myers Squibb
PII-145 - POPULATION PHARMACOKINETIC MODELING OF ALNUCTAMAB, A BCMA-BINDING T CELL ENGAGER, TO CHARACTERIZE THE BIOAVAILABILITY AND PHARMACOKINETICS IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)
Brian Kiesel
Favorite
Killam, Shayna

University of Montana
CT-003 - PERSPECTIVES ON PHARMACOGENETIC-GUIDED TOBACCO CESSATION IN AN AMERICAN INDIAN POPULATION
Shayna Killam
Favorite
PII-205 - PERSPECTIVES ON PHARMACOGENETIC-GUIDED TOBACCO CESSATION IN AN AMERICAN INDIAN POPULATION
Shayna Killam
Favorite
Kim, Heungjo

Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University
LB-018 - MODEL BASED META ANALYSIS OF IMATINIB PHARMACOKINETICS: IN ABCB1, ABCG2, AND CYP3A5 GENOTYPES.
Heungjo Kim
Favorite
Kim, Jae Hoon

Chungnam National University
E-001 - INVESTIGATION OF THE RELATIONSHIP BETWEEN LEPR GENOTYPE-LEPTIN-GUT MICROBIOTA COMPOSITION IN HEALTHY NON-OBESE KOREAN ADULTS.
Jae Hoon Kim
Favorite
Kim, Se Jin

SUNY at Buffalo
PII-002 - DEVELOPMENT OF A TRANSLATION PK-PD MODEL FOR IN VIVO CAR-T CELL THERAPIES USING CAR MRNA LOADED POLYMERIC NANOPARTICLE VECTOR
Se Jin Kim
Favorite
Kim, So-Yeon

Jeonbuk National University
CT-010 - COMPARATIVE PHARMACOKINETICS AND SAFETY OF DWJ1451 AND CO-ADMINISTRATION OF OLMESARTAN MEDOXOMIL/AMLODIPINE/ROSUVASTATIN AND EZETIMIBE TABLETS IN HEALTHY KOREAN SUBJECTS
So-Yeon Kim
Favorite
PII-106 - COMPARATIVE PHARMACOKINETICS AND SAFETY OF DWJ1451 AND CO-ADMINISTRATION OF OLMESARTAN MEDOXOMIL/AMLODIPINE/ROSUVASTATIN AND EZETIMIBE TABLETS IN HEALTHY KOREAN SUBJECTS
So-Yeon Kim
Favorite
Kotsybar, Joseph

U.S. Food and Drug Administration
PII-190 - GLOBAL HARMONIZATION OF IMMEDIATE-RELEASE SOLID ORAL DRUG PRODUCT BIOEQUIVALENCE RECOMMENDATIONS AND THE IMPACT ON GENERIC DRUG DEVELOPMENT.
Joseph Kotsybar
Favorite
Kowalski, Karey

Pfizer, Inc.
PII-100 - BOSUTINIB MODEL-INFORMED PEDIATRIC DOSE RECOMMENDATIONS FOR LABEL SIMPLIFICATION
Karey Kowalski
Favorite
Kuo-Esser, Lance

University of California, San Francisco
PII-036 - EFAVIRENZ AND DOLUTEGRAVIR MAY ALTER SIROLIMUS METABOLISM IN PEOPLE WITH HIV
Lance Kuo-Esser
Favorite
Kyler, Kathryn

Children's Mercy Kansas City
PII-175 - PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY.
Kathryn Kyler
Favorite